The Moderna flu jab has a comically bad risk-benefit ratio. Will the FDA give into political pressure and approve it?
Moderna just published the full results from its pivotal 40,000-person trial comparing its mRNA flu jab to a standard flu shot. They are awful. Not that you would know from the legacy media’s coverage, or Moderna’s press release promising “potential approvals expected to begin in 2026.” The trial showed severe side effects from the mRNA […]
Discuss on Nostr!
Nostr Note ID note1w83kgk6unzwvvte4rkrgmaj5hhxuy3v9umyt0u0ylux4anywu6cskrmu3h Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send cryptocurrency to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Send altcoins or fiat:
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.